Literature DB >> 10338262

The overactive bladder: an overview for primary care health providers.

A J Wein1, E S Rovner.   

Abstract

The overactive bladder, with symptoms of frequency, urgency and urge incontinence, substantially affects the life styles of millions of people throughout the world. The symptoms are associated with significant social, psychological, occupational, domestic, physical, and sexual problems. Despite the considerable impact of the condition on quality of life, sufferers are often reluctant to discuss their problem with family members or health care professionals. This state of affairs is unfortunate, for much can be done to alleviate the symptoms of this distressing condition. It is therefore of utmost importance that medical education about symptoms of the overactive bladder and other related problems be improved, to help health care professionals identify and treat patients who will benefit from therapy. This article reviews current thinking regarding definition, epidemiology, quality of life effects, evaluation and management. Emphasis is placed on knowledge particularly useful in primary care, especially, noninvasive modalities of therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10338262

Source DB:  PubMed          Journal:  Int J Fertil Womens Med        ISSN: 1534-892X


  12 in total

1.  Fluctuations in lower urinary tract symptoms in women. Reassurance and watchful waiting can prevent overtreatment.

Authors:  S Hunskaar
Journal:  BMJ       Date:  2000-05-27

2.  AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder.

Authors:  S Sinha; S Gupta; S Malhotra; N S Krishna; A V Meru; V Babu; V Bansal; M Garg; N Kumar; A Chugh; A Ray
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 3.  Tolterodine: a review of its use in the treatment of overactive bladder.

Authors:  D Clemett; B Jarvis
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Food does not influence the pharmacokinetics of a new extended release formulation of tolterodine for once daily treatment of patients with overactive bladder.

Authors:  B Olsson; J Szamosi
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Related factors of urge, stress, mixed urinary incontinence and overactive bladder in reproductive age women in Tabriz, Iran: a cross-sectional study.

Authors:  Sahar Sadat Sobhgol; Sakineh Mohamad Alizadeh Charandabee
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-08-18

6.  Maximizing the treatment of overactive bladder in the elderly.

Authors:  Scott A Macdiarmid
Journal:  Rev Urol       Date:  2008

7.  Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.

Authors:  Ananias Diokno; Peter Sand; Richard Labasky; Paul Sieber; Joseph Antoci; Gary Leach; Linda Atkinson; Detlef Albrecht
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder.

Authors:  Pat Ray Reese; Andreas M Pleil; Gary J Okano; Con J Kelleher
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

9.  Absolute bioavailability of imidafenacin after oral administration to healthy subjects.

Authors:  Tomoya Ohno; Susumu Nakade; Kazuki Nakayama; Junsaku Kitagawa; Shinya Ueda; Hiroyuki Miyabe; Yuichi Masuda; Yasuyuki Miyata
Journal:  Br J Clin Pharmacol       Date:  2008-02       Impact factor: 4.335

10.  The overlap of interstitial cystitis/painful bladder syndrome and overactive bladder.

Authors:  Maurice K Chung; Charles W Butrick; Cherie W Chung
Journal:  JSLS       Date:  2010-04-21       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.